You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
经济师料疫苗不会即时刺激美国经济 需要更大财政刺激
阿思达克 11-11 12:05
辉瑞(PFE.US)及BioNTech(BNTX.US)研发新冠疫苗获重大进展,刺激全球股市。Northern Trust首席经济师Carl Tannenbaum在《CNBC》节目上称,新冠疫苗不会对美国经济带来即时刺激;由於复苏势头放缓,需要更大的财政刺激。

Tannenbaum称,疫苗新闻及10月美国职位增长胜预期,属令人鼓舞的发展,但这不代表不需要进一步经济刺激。在就业面上,美国仍有约1,000万国民1月时有工作,但现在未能上岗;而现时失业人士在迈向全民就业上要走的路更长。他们仍需要支持。

另一方面,美国面对的困局在於在收入减少的时候,州政府及地方政府预算呈严重脱节。他们在裁员,削减服务,不利於经济。这亦是为甚麽美国不能依赖疫苗解决所有问题。

他解释,即使辉瑞及BioNTech疫苗今年获准使用,至2021年仍未有足够剂量提供予所需人士。Tannenbaum补充,由於国会分裂,不预期美国新一任总统在明年1月上任前会有经济刺激方案落地。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account